Screening of Gastrointestinal Tract Bleeding Causes Among Chronic Renal Failure Patients
1 other identifier
observational
100
0 countries
N/A
Brief Summary
The aim of the current study is to screen different causes and characteristics of Gastrointestinal bleeding in Chronic Renal Failure patients at Assuit University Hospital according to their stages based on e GFR (Stage I to IV), in order to assess different modalities of therapeutic intervention from medical therapy up to therapeutic intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2020
CompletedFirst Posted
Study publicly available on registry
July 29, 2020
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedJuly 29, 2020
July 1, 2020
1 year
July 25, 2020
July 28, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Assessment of different modalities of therapeutic intervention.
medical therapy up to therapeutic intervention data will be received.
one year from October 2020 to October 2021
Interventions
Chronic Renal Failure staging according to GFR by Chronic Renal Failure EPI is: * Stage1 in which GFR\>90 mil/min but evidence of kidney damage. * Stage 2 GFR 60-89 mil/min. * Stage 3 GFR 30-95 mil/min. * Stage 4 GFR 15-29 mil/min. * Stage 5 GFR\<15 mil/min.
Eligibility Criteria
Chronic Renal Failure patients with different stages (stage I to IV) according to the National Kidney Foundation are recruited from inpatients of renal unit in internal medicine department, Assuit university hospitals.
You may qualify if:
- One hundred Chronic Renal Failure patients with different stages (stage I to IV) according to the National Kidney Foundation are recruited from inpatients of renal unit in internal medicine department, Assuit university hospitals. Their GFR will assessed by using Chronic Renal Failure EPI equation measured as GFR=166 x(s cr/0.7)-1.209X(0.993)age if female, and GFR=163X(s cr/0.9)-1.209x(0.993)age if male. (Andrews et al 2008).
- Chronic Renal Failure staging according to GFR by Chronic Renal Failure EPI is:
- Stage1 in which GFR\>90 mil/min but evidence of kidney damage.
- Stage 2 GFR 60-89 mil/min.
- Stage 3 GFR 30-95 mil/min.
- Stage 4 GFR 15-29 mil/min.
- Stage 5 GFR\<15 mil/min.
You may not qualify if:
- All Patients with local causes of Gastrointestinal Bleeding
- Benign and Malignant tumors in Gastrointestinal Tract.
- Patients with Hemorrhoids or anal fissures.
- Patients with Mallory-Weiss tears.
- patients with Diverticular disease.
- patients with Colon polyps.
- patients with infectious causes of GIT bleeding (Salmonella, Shigella)
- patients with Angiodysplasia.
- patients with Esophageal varices
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (5)
Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, Sinclair P; International Consensus Upper Gastrointestinal Bleeding Conference Group. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010 Jan 19;152(2):101-13. doi: 10.7326/0003-4819-152-2-201001190-00009.
PMID: 20083829BACKGROUNDZuccaro G Jr. Management of the adult patient with acute lower gastrointestinal bleeding. American College of Gastroenterology. Practice Parameters Committee. Am J Gastroenterol. 1998 Aug;93(8):1202-8. doi: 10.1111/j.1572-0241.1998.00395.x. No abstract available.
PMID: 9707037BACKGROUNDKim BS, Li BT, Engel A, Samra JS, Clarke S, Norton ID, Li AE. Diagnosis of gastrointestinal bleeding: A practical guide for clinicians. World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):467-78. doi: 10.4291/wjgp.v5.i4.467.
PMID: 25400991BACKGROUNDStevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.
PMID: 23732715BACKGROUNDIshigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019 Apr;23(4):437-447. doi: 10.1007/s10157-018-1641-8. Epub 2018 Sep 3.
PMID: 30178234BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Effat AH Tony, Prof. Dr.
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
July 25, 2020
First Posted
July 29, 2020
Study Start
October 1, 2020
Primary Completion
October 1, 2021
Study Completion
December 1, 2021
Last Updated
July 29, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share